From: Using group testing in a two-phase epidemiologic design to identify the effects of a large number of antibody reactions on disease risk
Sensitivity
0.950.98
0.98
Power
0.877
0.886
False Positive Rate
0.058
0.062
Expected # of Tests
4,705,193
4,747,283